Mismatch Repair Deficient (dMMR) clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants with select solid tumors.
Orange, California and other locations